CLGN - CollPlant Net earnings per share (EPS TTM)
The EPS TTM history on the GURU.Markets service demonstrates profit dynamics, where the current level is -9.43. CollPlant Biotechnologies (CLGN) is developing an exclusive plant-based collagen platform while avoiding price dumping. Growth is driven by the precision of regenerative technologies and licensing deals. High barriers to entry are ensured by genetic engineering patents and strict medical oversight.
CollPlant - analytical breakdowns and key metrics (CLGN)
- share price and expert price forecast:
- market capitalization statistics:
- business book valuation details:
- debt and liquidity data:
Debt to Equity CollPlant Biotechnologies|CLGN - Long-Term Debt to Equity|Short-Term Debt to Equity CollPlant Ltd|CLGN - Company Aggregate Indebtedness|Debt to Book Capitalization Ratio CollPlant Biotechnologies Ltd.|CLGN - Company Long-Term Debt|Company Short-Term Debts CollPlant Biotechnologies|Quick Liquidity collplant.com
- earnings and multiples data:
CLGN - Company Profit|Future Profit CollPlant Biotechnologies|CLGN - Market Price to Net Income Ratio|Projected Price to Earnings CollPlant Ltd|CLGN - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple CollPlant Biotechnologies Ltd.|CLGN - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) CollPlant Biotechnologies|CLGN - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months collplant.com|CLGN - Earnings per share growth rate in current year|Expected earnings per share growth for next year CollPlant Biotechnologies
Summary company analysis:CLGN - collplant.com
For CollPlant Biotechnologies (CLGN), the rolling annual net income per share serves as an indicator of the monetization efficiency of its bioprinting technologies. This metric assesses the portion of profit attributable to a single security over the last 12 months. The calculation is based on the ratio of total income to the total number of shares outstanding. Positive momentum confirms the sustainability of the rhCollagen expansion model within regenerative medicine, while a negative trend signals risks under tight monetary policy.
Competitor analysis for CollPlant Biotechnologies
HCA: Net earnings per share for the last 12 months|tenethealth.com - Earnings per share for the last four quarters|FMS: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Solventum Corp|Earnings per share for the last twelve months Encompass Health Inc.|Net earnings per one share for the last twelve months Universal Health Services Corp UHS|Earnings per share for the last twelve months DaVita Inc. (DVA)|Earnings per share for the last twelve months RDNT (radnet.com)|Earnings per share for the last twelve months Option Care Health, Inc. OPCH|Surgery Partners Inc - Earnings per share for the last twelve months|PINC - Earnings per share for the last twelve months|Earnings per one share for the last 12 months EYE|Progyny, Inc. (PGNY) - Earnings per share for the last twelve months|ARDT (ardenthealth.com) - Earnings per share for the last twelve months|SEM (Select Medical Holdings) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Astrana Health Inc|Earnings per share for the last twelve months MEDNAX (MD)|usph.com - Earnings per share for the last 12 months|The Pennant Group, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ORGO (organogenesis.com)|NUTX: Net earnings per share for the last 12 months|Earnings per share for the trailing year AUNA (Auna S.A.)|SBC: Net earnings per share (EPS TTM)|EOLS (Evolus Corp) - Earnings per share for the last twelve months|CYH (Community Health Systems) - Net earnings per share (EPS TTM)|Beauty Health (SKIN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months MediWound Ltd. (MDWD)|BTMD - Net earnings per one share for the last twelve months|The Joint Corporation - Net earnings per share for the last 12 months|Earnings per share for the last four quarters DCGO (DocGo, Inc)|P3 Health - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Gain Therapeutics Inc.|EUDA: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Basel Medical Group Ltd|CUPR (Cuprina Holdings Ltd) - Net earnings per share (EPS TTM)|CCM: Earnings per share for the trailing year|Earnings per share for the last twelve months American Shared Hospital (AMS)|medirom.co.jp - Earnings per share for the last 12 months|Earnings per share for the last twelve months Avalon GloboCare Corp. ALBT|DIH Holding US (DHAI) - Net earnings per one share for the last twelve months|XAGE - Earnings per share for the last twelve months|NIVF: Earnings per share for the last twelve months|atipt.com (ATIP) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months caremax.com (CMAX)|KDLY (Kindly MD) - Net earnings per share (EPS TTM)|MODV - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) NVOS|Net earnings per share for the last four quarters sunlinkhealth.com|Net earnings per share (EPS TTM) BACK (IMAC Holdings, Inc.)
